oral Covid-19 drug

Pharmaceutical company Merck said Friday it will seek authorisation in the US for an oral drug for Covid-19, after the pill showed “compelling results” in a clinical trial. The experimental drug, molnupiravir, significantly reduced the risk of hospitalisation or death when administered to high-risk patients early in the disease, Merck and its partner Ridgeback Biotherapeutics … Read more